The State Organization Index provides an alphabetical listing of government organizations, including commissions, departments, and bureaus.
Top-requested sites to log in to services provided by the state
Prescribers and pharmacists have asked whether Adderall® , a Schedule II amphetamine product, may be dispensed in a sixty day supply. Adderall® has federal Food and Drug Administration (FDA) indications for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and narcolepsy.
The Drug Control Program and the Board of Registration in Pharmacy have determined that methylphenidate and single entity drug products containing the dextro and/or levo isomers of amphetamine may be dispensed in a sixty day supply when prescribed for an inattention and impulsivity-hyperactivity disorder or narcolepsy.
Quantity limits for controlled substances in Schedules II and III are set forth in M.G.L. 94C § 23(d) which reads, in part, as follows:
For the purposes of fulfilling the intent of the statute, the DCP and the Board find that:
Therefore, a patient with narcolepsy, Attention Deficit/Hyperactivity Disorder (ADHD) or other inattention and impulsivity-hyperactivity disorder may now obtain a sixty day supply of Adderall® (there is no requirement that the diagnosis be written on the prescription).